Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
PREGNANCY: Atazanavir has not been adequately studied in pregnant women.
NURSING MOTHERS: Atazanavir has not been adequately studied in nursing mothers. Scientific experts advise HIV-infected mothers not to breast-feed because of the risk of transmitting HIV to the infant.
SIDE EFFECTS: The most common side effects of atazanavir are rash, nausea, diarrhea, vomiting, headache and abdominal pain. Atazanavir may cause jaundice by increasing bilirubin in the blood. Some patients also may see an increase in blood glucose levels or an increase or redistribution of body fat. Changes in body fat may include increased fat in the upper back and neck (buffalo hump), trunk and breasts. In a small number of patients atazanavir may decrease heart rate. In a small number of patients a serious condition called lactic acidosis--a build up of acid in the blood--may occur. Symptoms of lactic acidosis include persistent nausea, vomiting, weakness and trouble breathing. Individuals with bleeding disorders may bleed more when taking atazanavir.
HIV (human immunodeficiency virus) is the cause of AIDS (acquired immunodeficiency syndrome). HIV is a type of virus called a retrovirus, which infects humans when it comes in contact with a break in the skin or tissues such as those that line the vagina, anal area, mouth, or eyes.